Researchers show the interplay of socioeconomic status and genetics on disease risk
Differences in socioeconomic status (SES) are known to be linked to differences in the risk of developing disease.
Differences in socioeconomic status (SES) are known to be linked to differences in the risk of developing disease.
Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and
Some women who experience menopause early-;before age 40-;have an increased risk for developing breast and ovarian cancer, according to research being presented Monday at ENDO
A novel male contraceptive gel combining two hormones, segesterone acetate (named Nestorone) and testosterone, suppresses sperm production faster than similar experimental hormone-based methods for male
Dive Brief: Abbott received clearance from the Food and Drug Administration for an over-the-counter glucose monitor. The device, called Lingo, first debuted in the U.K.
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: BD has agreed to buy
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Venture capital investment in medtech
Illinois released its cannabis sales data much later than it normally does. Illinois adult-use cannabis sales in April were down 2.9% sequentially to a $144.5 million, which was
Older women with low bone density are more likely to experience their first hip fracture in their 60s compared to older ages, according to research
VANCOUVER, BC, June 3, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today